Cargando…

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes

OBJECTIVE: To examine the loss of glucagon response to hypoglycemia and its relationship with residual β-cell function early in the course of type 1 diabetes (T1D) in youth. RESEARCH DESIGN AND METHODS: Twenty-one youth with T1D duration <1 year (ages 8–18 years, T1D duration 6–52 weeks) underwen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherr, Jennifer, Xing, Dongyuan, Ruedy, Katrina J., Beck, Roy W., Kollman, Craig, Buckingham, Bruce, White, Neil H., Fox, Larry, Tsalikian, Eva, Weinzimer, Stuart, Arbelaez, Ana Maria, Tamborlane, William V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661789/ https://www.ncbi.nlm.nih.gov/pubmed/23288858 http://dx.doi.org/10.2337/dc12-1697

Ejemplares similares

Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis
por: Sherr, Jennifer, et al.
Publicado: (2014)

Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual β-Cell Function
por: Sherr, Jennifer, et al.
Publicado: (2012)

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
por: Mauras, Nelly, et al.
Publicado: (2012)

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
por: Tansey, Michael, et al.
Publicado: (2013)

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2016)

Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia
por: Mauras, Nelly, et al.
Publicado: (2015)

Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
por: Buckingham, Bruce, et al.
Publicado: (2013)

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study
por: Rickels, Michael R., et al.
Publicado: (2016)

Neuroanatomical Correlates of Dysglycemia in Young Children With Type 1 Diabetes
por: Marzelli, Matthew J., et al.
Publicado: (2014)

Persistence of Individual Variations in Glycated Hemoglobin: Analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial
por: Wilson, Darrell M., et al.
Publicado: (2011)

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
por: Rickels, Michael R., et al.
Publicado: (2016)

Alterations in White Matter Structure in Young Children With Type 1 Diabetes
por: Barnea-Goraly, Naama, et al.
Publicado: (2014)

Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes
por: Hughes, Allyson S., et al.
Publicado: (2023)

A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes
por: Reiss, Allan L., et al.
Publicado: (2022)

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2013)

Duration of Nocturnal Hypoglycemia Before Seizures
por: Buckingham, Bruce, et al.
Publicado: (2008)

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis
por: Buckingham, Bruce A., et al.
Publicado: (2015)

“It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes
por: Hughes, Allyson S., et al.
Publicado: (2022)

Early Pharmacokinetic and Pharmacodynamic Effects of Mixing Lispro With Glargine Insulin: Results of glucose clamp studies in youth with type 1 diabetes
por: Cengiz, Eda, et al.
Publicado: (2010)

Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia
por: Pontiroli, Antonio E., et al.
Publicado: (2019)

The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin
por: Cengiz, Eda, et al.
Publicado: (2012)

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
por: Kedia, Nitil
Publicado: (2011)

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197–1204
por: Buckingham, Bruce A., et al.
Publicado: (2015)

Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons
por: Pontiroli, Antonio E., et al.
Publicado: (2022)

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes
por: Siafarikas, Aris, et al.
Publicado: (2012)

A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia
por: Lobato, Carolina B., et al.
Publicado: (2020)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes
por: Laffel, Lori M., et al.
Publicado: (2017)

Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart
por: Aranda-Domene, Ramón, et al.
Publicado: (2023)

The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
por: Huang, Elbert S., et al.
Publicado: (2010)

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

Mitochondrial GTP Insensitivity Contributes to Hypoglycemia in Hyperinsulinemia Hyperammonemia by Inhibiting Glucagon Release
por: Kibbey, Richard G., et al.
Publicado: (2014)

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
por: Ja’arah, Daria, et al.
Publicado: (2021)

Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
por: Osumili, Beatrice, et al.
Publicado: (2022)

Why Glucagon Matters for Hypoglycemia and Physical Activity in Individuals With Type 1 Diabetes
por: Colberg, Sheri R.
Publicado: (2022)

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
por: Weinzimer, Stuart A., et al.
Publicado: (2012)

Neonatal hypoglycemia: lack of evidence for a safe management
por: Roeper, Marcia, et al.
Publicado: (2023)

A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes
por: Maahs, David M., et al.
Publicado: (2014)

Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study
por: Yale, Jean-François, et al.
Publicado: (2017)

Puzzling About Partial Glucagon Responses to Hypoglycemia in Intrahepatic Islet Recipients: Missing Pieces
por: Robertson, R. Paul
Publicado: (2015)

Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion
por: Picard, Alexandre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rtgeuubj9d270bgn8jh4gqelq8